Drug profile · INN
deferasirox
DEFERASIROX ACCORD
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
deferasirox (DEFERASIROX ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN deferasirox
Brand DEFERASIROX ACCORD
Route ORAL
Formulation GRANULE
ATC code V03AC03
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is deferasirox?
deferasirox (DEFERASIROX ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for deferasirox?
DEFERASIROX ACCORD is a marketed brand name for deferasirox. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of deferasirox?
deferasirox has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.